3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
184
Mesothelioma, Malignant
183
Mesothelioma
145
Solid Tumor
135
Retinoblastoma
96
Solid Tumors
86
Advanced Solid Tumor
60
Advanced Solid Tumors
50
Solid Tumor, Adult
47
Hematopoietic and Lymphatic System Neoplasm
47
Carcinoma, Non-Small-Cell Lung
42
Lung Neoplasms
33
Sarcoma
28
Hematopoietic and Lymphoid System Neoplasm
23
Small Cell Lung Carcinoma
21
Pancreatic Neoplasms
20
Stomach Neoplasms
19
Neuroblastoma
19
Melanoma
19
Carcinoma, Renal Cell
19
Ovarian Neoplasms
18
Neoplasms
17
Wilms Tumor
15
Colorectal Neoplasms
15
Breast Neoplasms
15
Osteosarcoma
13
Solitary Fibrous Tumor, Pleural
12
Rhabdomyosarcoma
12
Refractory Solid Tumors
12
Esophageal Neoplasms
12
Interventions
spartalizumab
1
pazopanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Refractory or Recurrent Solid Tumor
×
Other solid neoplasm
×
Clear all
NCT05210413
2026-01-15
SPARTO
University Hospital, Bordeaux
Phase 1/2
Active not recruiting
80 enrolled